CareCloud (MTBC) Q3 2024 earnings summary

Executive summary

• Achieved record free cash flow of $10.3M for the first nine months of 2024, up 328% year-over-year, and fully repaid a $10M credit line using internally generated cash.

• Returned to profitability with $3.1M GAAP net income in Q3 2024, reversing a $2.7M net loss in Q3 2023; nine-month net income was $4.6M versus a $5.0M loss last year.

• Implemented significant cost reductions, targeting $26M in expense cuts by year-end, with $20M realized in 2024, and suspended preferred stock dividends to improve liquidity.

• Will resume monthly dividend payments on Series A and B preferred shares in March 2025, reflecting confidence in ongoing profitability.

• Integration of generative AI and restructuring are expected to drive further efficiencies and profitability in 2025.

Financial highlights

• Q3 2024 revenue was $28.5M, down 2.5–3% year-over-year; nine-month revenue was $82.6M, down from $88.6M in 2023.

• Q3 2024 adjusted EBITDA was $6.8M (24% margin), up 111% year-over-year; nine-month adjusted EBITDA was $16.9M, up 50% from $11.3M in 2023.

• Q3 2024 free cash flow was $5.4M, up 391–405% year-over-year; nine-month free cash flow was $10.3M, up 328–391%.

• Q3 2024 GAAP net income was $3.1M; nine-month GAAP net income was $4.6M.

• Cash at September 30, 2024, was $2.8M; net working capital was $732,000.

Outlook and guidance

• Updated full-year 2024 adjusted EBITDA guidance to $23–$25M, up from prior guidance.

• Reaffirmed full-year 2024 revenue guidance of $109–$111M, based on existing client revenues.

• Management expects continued cost reductions, improved cash flow, and profitability through 2024, with focus on AI integration and value creation.

• Sufficient liquidity is projected for the next twelve months; focus remains on compliance with debt covenants.

• Preferred dividends on Series A and B shares are set to resume in March 2025.